POSACONAZOL ZENTIVA 100mg gastro-resistant tablets medication leaflet

J02AC04 posaconazole • Antiinfectives for systemic use | Antimycotics for systemic use | Triazole derivatives


Posaconazolum is an antifungal medication used for the prevention and treatment of severe fungal infections, such as invasive aspergillosis or oropharyngeal candidiasis.
It belongs to the triazole class and works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to fungal destruction.

Posaconazolum is particularly indicated for immunocompromised patients, such as those who have undergone organ transplants or are undergoing chemotherapy.
The medication is available as an oral suspension, tablets, or injectable solution, with the dosage adjusted based on the severity of the infection and the patient's condition.

Common side effects include nausea, diarrhea, headaches, and elevated liver enzyme levels.
In rare cases, more serious adverse effects may occur, such as hepatotoxicity or severe allergic reactions.

It is important for patients to strictly follow their doctor's recommendations and undergo regular liver function tests during treatment.
Posaconazolum may interact with other medications, so patients should inform their doctor about all treatments they are taking.

General data about POSACONAZOL ZENTIVA 100mg

Substance: posaconazole

Date of last drug list: 01-06-2025

Commercial code: W66364009

Concentration: 100mg

Pharmaceutical form: gastro-resistant tablets

Quantity: 24

Product type: generic

Price: 1267.79 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: DELORBIS PHARMACEUTICALS LTD - CIPRU

Holder: ZENTIVA K.S. - REP. CEHA

Number: 12621/2019/09

Shelf life: 30 months

Concentrations available for posaconazole

100mg, 300mg, 40mg/ml

Other substances similar to posaconazole

Compensation lists for POSACONAZOL ZENTIVA 100mg ZENTIVA

G10 (C1) - Leukemias, lymphomas and spinal cord aplasia, tumors

Price

Copayment

Patient

1267.79 RON

989.95 RON

277.84 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

1267.79 RON

989.95 RON

277.84 RON

NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment

Price

Copayment

Patient

1267.79 RON

989.95 RON

277.84 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

1267.79 RON

989.95 RON

277.84 RON

NHP 9.7 (C2) - Outpatient treatment of transplant patients

Price

Copayment

Patient

1267.79 RON

989.95 RON

277.84 RON